Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3713)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
May 20, 2022 (publication date) through Jul 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Methodology
ISSN
2222-0682
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Messori A. Lutetium in prostate cancer: Reconstruction of patient-level data from published trials and generation of a multi-trial Kaplan-Meier curve. World J Methodol 2022; 12(3): 107-112 [PMID: 35721242 DOI: 10.5662/wjm.v12.i3.107] |
|---|---|
| URL: | https://www.wjgnet.com/2222-0682/full/v12/i3/107.htm |
| Number | Citing Articles |
| 1 |
Keisuke Hanada, Tomoyuki Sugimoto. Meta-Analysis for Time-to-event Outcome Based on Restored Individual Participant Data and Summary Statistics. Japanese Journal of Biometrics 2024; 45(1): 115 doi: 10.5691/jjb.45.115
|
| 2 |
Andrea Messori, Melania Rivano, Luca Cancanelli, Vera Damuzzo, Andrea Ossato, Marco Chiumente, Daniele Mengato. The “One-to-Many” Survival Analysis to Evaluate a New Treatment in Comparison With Therapeutic Alternatives Based on Reconstructed Patient Data: Enfortumab Vedotin Versus Standard of Care in Advanced or Metastatic Urothelial Carcinoma. Cureus 2022; doi: 10.7759/cureus.28369
|
| 3 |
Andrea Messori, Vera Damuzzo, Melania Rivano, Luca Cancanelli, Lorenzo Di Spazio, Andrea Ossato, Marco Chiumente, Daniele Mengato. Application of the IPDfromKM-Shiny Method to Compare the Efficacy of Novel Treatments Aimed at the Same Disease Condition: A Report of 14 Analyses. Cancers 2023; 15(6): 1633 doi: 10.3390/cancers15061633
|
| 4 |
Andrea Ossato, Vera Damuzzo, Paolo Baldo, Daniele Mengato, Marco Chiumente, Andrea Messori. Immune checkpoint inhibitors as first line in advanced melanoma: Evaluating progression‐free survival based on reconstructed individual patient data. Cancer Medicine 2023; 12(3): 2155 doi: 10.1002/cam4.5067
|
| 5 |
Amene Saghazadeh, Nima Rezaei. Handbook of Cancer and Immunology. 2023; : 1 doi: 10.1007/978-3-030-80962-1_309-1
|